Comparison of liver cancer incidence and survival by subtypes across seven high‐income countries-Reference-Cited by-同舟云学术

Comparison of liver cancer incidence and survival by subtypes across seven high‐income countries

Published:2021-09-14 Issue:12 Volume:149 Page:2020-2031
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Rutherford Mark J.¹²^ORCID,Arnold Melina¹^ORCID,Bardot Aude¹,Ferlay Jacques¹^ORCID,De Prithwish³,Tervonen Hannah⁴,Little Alana⁴,Bucher Oliver⁵,St Jacques Nathalie⁶,Gavin Anna⁷,Engholm Gerda⁸,Møller Bjørn⁹,O'Connell Dianne L.¹⁰,Merrett Neil¹¹,Parkin Donald Maxwell¹¹²^ORCID,Bray Freddie¹^ORCID,Soerjomataram Isabelle¹^ORCID

Affiliation:

1. International Agency for Research on Cancer Lyon France

2. Biostatistics Research Group University of Leicester Leicester UK

3. Analytics and Informatics, Cancer Care Ontario Toronto Ontario Canada

4. Cancer Institute NSW Alexandria Australia

5. Department of Epidemiology and Cancer Registry, CancerCare Manitoba Winnipeg Manitoba Canada

6. Nova Scotia Health Authority Cancer Care Program, Registry & Analytics Halifax Nova Scotia Canada

7. Northern Ireland Cancer Registry, Queen's University Belfast Belfast Northern Ireland UK

8. Danish Cancer Society Research Centre, Cancer Surveillance and Pharmacoepidemiology Copenhagen Denmark

9. Department of Registration, Cancer Registry of Norway Oslo Norway

10. The Daffodil Centre The University of Sydney (A Joint Venture with Cancer Council NSW) Camperdown Australia

11. School of Medicine Western Sydney University Campbelltown Australia

12. Nuffield Department of Population Health University of Oxford Oxford UK

Funder

Cancer Council Victoria

Cancer Institute NSW

Cancer Research UK

Kræftens Bekæmpelse

Kreftforeningen

Public Health Wales

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33767

Reference29 articles.

1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

2. ColemanM FormanD BryantH et al.Cancer survival in Australia Canada Denmark Norway Sweden and the UK 1995–2007 (the International Cancer Benchmarking Partnership): An analysis of population‐based cancer registry data;2011.

3. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

4. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

5. The International Cancer Benchmarking Partnership: An international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of cantharidin/baicalin co-delivery system based on mitochondrial targeting strategy for enhanced hepatocellular carcinoma therapy;Applied Materials Today;2024-10

2. Precise ablation zone segmentation on CT images after liver cancer ablation using semi‐automatic CNN‐based segmentation;Medical Physics;2024-09-09

3. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment;Medicina;2024-04-24

4. Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study;MED LAV;2024

5. Trends and future projections of liver cancer incidence in Hong Kong: a population-based study;Archives of Public Health;2023-10-03